,address1,city,state,zip,country,phone,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,shortPercentOfFloat,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationMean,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,20271 Goldenrod Lane,Germantown,MD,20876,United States,480 659 6404,https://www.orgenesis.com,Biotechnology,Healthcare,"Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.",167,"{'maxAge': 1, 'name': 'Ms. Vered  Caplan M.Sc.', 'age': 53, 'title': 'Chairperson of the Board, CEO & Pres', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 335968, 'exercisedValue': 875745, 'unexercisedValue': 448638}",1672444800,86400,4,0.7081,0.68,0.65,0.69,0.7081,0.68,0.65,0.69,0.0,1.062586,1.1311475,84172,84172,93411,90180,90180,0.6113,0.6899,2900,800,21022092,0.38,2.64,0.58999443,0.9196,1.42725,0.0,0.0,USD,40109096,-0.38643003,24750750,30466800,200429,180207,1690761600,1693440000,0.0066000004,0.118030004,0.12569,1.21,0.0067000003,0.842,0.81947744,1672444800,1703980800,1688083200,-13769000,-0.49,0.61,1:12,1510790400,1.126,-10.208,NCM,EQUITY,ORGS,ORGS,Orgenesis Inc.,Orgenesis Inc.,1331645400,America/New_York,EDT,-14400000,0.69,2.0,buy,180000,0.006,-3929000,20647000,0.091,0.731,35631000,86.155,1.35,-0.06493,-0.37995,36025000,3936875,-28872000,-0.031,0.88277,-0.11027,-0.1714,USD,
1,20271 Goldenrod Lane,Germantown,MD,20876,United States,480 659 6404,https://www.orgenesis.com,Biotechnology,Healthcare,"Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.",167,"{'maxAge': 1, 'name': 'Prof. Sarah  Ferber Ph.D.', 'age': 68, 'title': 'Founder & Chief Scientific Officer', 'yearBorn': 1954, 'fiscalYear': 2018, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.7081,0.68,0.65,0.69,0.7081,0.68,0.65,0.69,0.0,1.062586,1.1311475,84172,84172,93411,90180,90180,0.6113,0.6899,2900,800,21022092,0.38,2.64,0.58999443,0.9196,1.42725,0.0,0.0,USD,40109096,-0.38643003,24750750,30466800,200429,180207,1690761600,1693440000,0.0066000004,0.118030004,0.12569,1.21,0.0067000003,0.842,0.81947744,1672444800,1703980800,1688083200,-13769000,-0.49,0.61,1:12,1510790400,1.126,-10.208,NCM,EQUITY,ORGS,ORGS,Orgenesis Inc.,Orgenesis Inc.,1331645400,America/New_York,EDT,-14400000,0.69,2.0,buy,180000,0.006,-3929000,20647000,0.091,0.731,35631000,86.155,1.35,-0.06493,-0.37995,36025000,3936875,-28872000,-0.031,0.88277,-0.11027,-0.1714,USD,
2,20271 Goldenrod Lane,Germantown,MD,20876,United States,480 659 6404,https://www.orgenesis.com,Biotechnology,Healthcare,"Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.",167,"{'maxAge': 1, 'name': 'Mr. Elliot  Maltz CPA', 'age': 38, 'title': 'Chief Financial Officer', 'yearBorn': 1984, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.7081,0.68,0.65,0.69,0.7081,0.68,0.65,0.69,0.0,1.062586,1.1311475,84172,84172,93411,90180,90180,0.6113,0.6899,2900,800,21022092,0.38,2.64,0.58999443,0.9196,1.42725,0.0,0.0,USD,40109096,-0.38643003,24750750,30466800,200429,180207,1690761600,1693440000,0.0066000004,0.118030004,0.12569,1.21,0.0067000003,0.842,0.81947744,1672444800,1703980800,1688083200,-13769000,-0.49,0.61,1:12,1510790400,1.126,-10.208,NCM,EQUITY,ORGS,ORGS,Orgenesis Inc.,Orgenesis Inc.,1331645400,America/New_York,EDT,-14400000,0.69,2.0,buy,180000,0.006,-3929000,20647000,0.091,0.731,35631000,86.155,1.35,-0.06493,-0.37995,36025000,3936875,-28872000,-0.031,0.88277,-0.11027,-0.1714,USD,
3,20271 Goldenrod Lane,Germantown,MD,20876,United States,480 659 6404,https://www.orgenesis.com,Biotechnology,Healthcare,"Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.",167,"{'maxAge': 1, 'name': 'Dan  Slonim', 'title': 'COO & GM of Orgenesis Israel', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.7081,0.68,0.65,0.69,0.7081,0.68,0.65,0.69,0.0,1.062586,1.1311475,84172,84172,93411,90180,90180,0.6113,0.6899,2900,800,21022092,0.38,2.64,0.58999443,0.9196,1.42725,0.0,0.0,USD,40109096,-0.38643003,24750750,30466800,200429,180207,1690761600,1693440000,0.0066000004,0.118030004,0.12569,1.21,0.0067000003,0.842,0.81947744,1672444800,1703980800,1688083200,-13769000,-0.49,0.61,1:12,1510790400,1.126,-10.208,NCM,EQUITY,ORGS,ORGS,Orgenesis Inc.,Orgenesis Inc.,1331645400,America/New_York,EDT,-14400000,0.69,2.0,buy,180000,0.006,-3929000,20647000,0.091,0.731,35631000,86.155,1.35,-0.06493,-0.37995,36025000,3936875,-28872000,-0.031,0.88277,-0.11027,-0.1714,USD,
4,20271 Goldenrod Lane,Germantown,MD,20876,United States,480 659 6404,https://www.orgenesis.com,Biotechnology,Healthcare,"Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.",167,"{'maxAge': 1, 'name': 'Dr. Shimon  Hassin Ph.D.', 'title': 'Chief Technology Officer', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.7081,0.68,0.65,0.69,0.7081,0.68,0.65,0.69,0.0,1.062586,1.1311475,84172,84172,93411,90180,90180,0.6113,0.6899,2900,800,21022092,0.38,2.64,0.58999443,0.9196,1.42725,0.0,0.0,USD,40109096,-0.38643003,24750750,30466800,200429,180207,1690761600,1693440000,0.0066000004,0.118030004,0.12569,1.21,0.0067000003,0.842,0.81947744,1672444800,1703980800,1688083200,-13769000,-0.49,0.61,1:12,1510790400,1.126,-10.208,NCM,EQUITY,ORGS,ORGS,Orgenesis Inc.,Orgenesis Inc.,1331645400,America/New_York,EDT,-14400000,0.69,2.0,buy,180000,0.006,-3929000,20647000,0.091,0.731,35631000,86.155,1.35,-0.06493,-0.37995,36025000,3936875,-28872000,-0.031,0.88277,-0.11027,-0.1714,USD,
5,20271 Goldenrod Lane,Germantown,MD,20876,United States,480 659 6404,https://www.orgenesis.com,Biotechnology,Healthcare,"Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.",167,"{'maxAge': 1, 'name': 'Ms. Osher Partok Rheinisch', 'age': 50, 'title': 'Gen. Counsel & Compliance Officer', 'yearBorn': 1972, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.7081,0.68,0.65,0.69,0.7081,0.68,0.65,0.69,0.0,1.062586,1.1311475,84172,84172,93411,90180,90180,0.6113,0.6899,2900,800,21022092,0.38,2.64,0.58999443,0.9196,1.42725,0.0,0.0,USD,40109096,-0.38643003,24750750,30466800,200429,180207,1690761600,1693440000,0.0066000004,0.118030004,0.12569,1.21,0.0067000003,0.842,0.81947744,1672444800,1703980800,1688083200,-13769000,-0.49,0.61,1:12,1510790400,1.126,-10.208,NCM,EQUITY,ORGS,ORGS,Orgenesis Inc.,Orgenesis Inc.,1331645400,America/New_York,EDT,-14400000,0.69,2.0,buy,180000,0.006,-3929000,20647000,0.091,0.731,35631000,86.155,1.35,-0.06493,-0.37995,36025000,3936875,-28872000,-0.031,0.88277,-0.11027,-0.1714,USD,
